Literature DB >> 24048237

Contemporary use of devices in heart failure.

A H Maass1, D J van Veldhuisen.   

Abstract

Devices have become a cornerstone of heart failure (HF) therapy. Implantable cardioverter-defibrillators (ICDs) decrease mortality, and cardiac resynchronization therapy (CRT) improves symptoms and mortality. Most data have been collected in patients with systolic dysfunction. Data in patients with preserved systolic function are scarce, but interesting therapeutic concepts are evolving. Besides therapeutic functions, devices can have add-on diagnostic features such as early detection of fluid overload. In addition, stand-alone diagnostic devices are now also being developed for HF.

Entities:  

Mesh:

Year:  2013        PMID: 24048237     DOI: 10.1038/clpt.2013.144

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  2 in total

1.  Diagnostic tests to predict outcome in patients with implantable cardioverter defibrillators: it is not that simple!

Authors:  A H Maass
Journal:  Neth Heart J       Date:  2014-10       Impact factor: 2.380

2.  Management of device-related malignant sarcoma.

Authors:  Arash Khamooshian; Theo J Klinkenberg; Alexander H Maass; Massimo A Mariani
Journal:  HeartRhythm Case Rep       Date:  2017-06-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.